PMVP

Pmv Pharmaceuticals, Inc.

• Simply Wall St·03/25 10:16

  PMV Pharmaceuticals Insider Sellers Vindicated After 11% Drop

• TipRanks·03/12 16:32

  PMV Pharmaceuticals Advances Rezatapopt Interaction Study, Signaling Steady Progress in TP53-Driven Oncology

• NASDAQ·03/09 09:15

  PMV Pharma Targets Q1'27 NDA Filing For Rezatapopt In Platinum-Resistant Ovarian Cancer

• Seeking Alpha·03/06 19:06

  PMV Pharmaceuticals GAAP EPS of -$1.48 beats by $0.06

• TipRanks·03/06 13:13

  PMV Pharmaceuticals reports FY25 EPS ($1.48), consensus ($1.51)

• TipRanks·03/06 13:12

  PMV Pharmaceuticals sees cash runway to end of 2Q27

• Benzinga·03/06 13:10

  PMV Pharma Q4 EPS $(0.34) Beats $(0.41) Estimate

• Dow Jones·03/06 13:05

  *PMV Pharmaceuticals 2025 EPS $1.48 >PMVP

• Reuters·03/06 13:01

  PMV Pharma FY 2025 net loss hits USD 77.7 million

• Reuters·03/06 13:00

  PMV PHARMACEUTICALS REPORTS FULL YEAR 2025 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS

• Dow Jones·03/06 13:00

  Press Release: PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights

• Dow Jones·03/06 13:00

  Press Release: PMV Pharmaceuticals Reports Full -2-

• Reuters·02/26 20:16

  Health Rounds: Researchers find cellular clues to explain faster pain recovery in men

• Benzinga·02/26 17:05

  12 Health Care Stocks Moving In Thursday's Intraday Session

• TipRanks·02/26 13:14

  PMV Pharmaceuticals announces results of Phase 1 trial of rezatapopt in NEJM